The honest eligibility guide for 2025, explaining who qualifies for NHS Wegovy, how the referral pathway works, what waiting times look like and when private treatment may be worth considering.
Wegovy (semaglutide) is one of the most talked-about weight loss injections in the UK — and for good reason. Clinical trials show it produces an average of 15% body weight loss over 68 weeks, it is approved by NICE, and it is technically available on the NHS.
But “technically available” and “practically accessible” are two very different things.
The honest answer to whether you can get Wegovy free on the NHS is: yes, but only for a narrow group of patients, only through a specific NHS pathway, and — in most parts of England — only after a wait that can stretch to two years or more.
This guide explains exactly who qualifies, what the NHS pathway involves, how long it takes, what happens if you are refused, and whether going private is worth considering in the meantime.
Quick summary: Wegovy is available on the NHS at standard prescription cost, £9.90 in England and free in Scotland, Wales and Northern Ireland, but only through specialist weight management services, only for patients meeting strict BMI and comorbidity criteria, and only after successful referral by your GP.
A simple infographic summary to help readers understand the main points before reading the full comparison.
Yes. NICE published guidance TA875 in March 2023 recommending semaglutide 2.4mg, the active ingredient in Wegovy, for weight management in eligible adults.
Wegovy is available on the NHS in England, Scotland and Wales. There is an important distinction, however, between availability and access.
While Wegovy is approved for NHS use, it can only be prescribed through specialist weight management services — not directly by your GP.
Demand for specialist weight management services has vastly outpaced capacity since the drug launched in September 2023. For most people, the practical reality is a significant wait.
Ozempic is not available on the NHS for weight loss. It is licensed for type 2 diabetes only, and NHS guidance is clear that it should not be prescribed for weight management.
To be prescribed Wegovy through the NHS, you must meet the criteria set out by NICE guidance TA875.
If your BMI is between 30 and 34.9, or 27.5 to 32.4 for the ethnic groups above, and you have weight-related health conditions, you may be eligible if you meet additional NHS criteria for specialist service referral.
Wegovy on the NHS is not available for people who simply want to lose weight without qualifying health conditions. It is a treatment for obesity as a clinical condition, not a lifestyle choice.
The reduced BMI thresholds for South Asian, Chinese, Middle Eastern, Black African and African-Caribbean backgrounds reflect clinical evidence that people from these groups face significantly higher risks of weight-related conditions at lower BMI values.
If you fall into these groups, the standard BMI cut-offs do not apply — you may be eligible at a lower BMI than you expect.
If you are prescribed Wegovy on the NHS and have not lost at least 5% of your starting body weight after six months, treatment will typically be stopped.
This is an NHS cost-effectiveness condition based on the clinical evidence. The drug is most beneficial for people who respond to it.
NHS Wegovy prescriptions are limited to a maximum of two years. This reflects the duration of the clinical trials on which NICE based its approval.
After two years on NHS Wegovy, you will not be prescribed further courses. Private treatment does not have this time limit.
Book an appointment specifically to discuss your weight and mention that you are interested in accessing weight management services. Bring records of previous weight loss attempts if you have them.
If your GP agrees you may be eligible, they will refer you to your local NHS specialist weight management service, usually Tier 3 or Tier 4.
Once referred, you join a waiting list for an initial assessment appointment. This is where the significant delay occurs for most patients.
The specialist team will assess your BMI, comorbidities, medical history, previous weight management attempts and psychological readiness.
If the team determines you are eligible and Wegovy is appropriate, it will be prescribed alongside structured dietary, exercise and psychological support.
Your GP can only refer you to a specialist service. They cannot write an NHS Wegovy prescription themselves.
Important: any GP offering to prescribe Wegovy directly on the NHS is likely prescribing it off-label, which is outside NICE guidance. If a GP offers Wegovy privately, this is a separate private prescription arrangement, not an NHS prescription.
Wegovy can be available through the NHS for eligible patients, but the pathway depends on BMI, health conditions, local services and waiting times.
Waiting times for NHS Tier 3 weight management services are substantial and vary enormously by location.
| Location / area | Approximate waiting time |
|---|---|
| National average, many areas | 12 to 24 months |
| Some urban services, London and Manchester | 18 to 36 months |
| Some rural areas | 6 to 12 months |
| Oviva, NHS-commissioned digital service | ~10 weeks |
| Private prescription | 3 working days or less |
Access also varies enormously by postcode. Two patients with identical BMI and health conditions living 20 miles apart may have radically different waiting times because of how their local Integrated Care Board has commissioned weight management services.
To qualify at the standard BMI threshold of 35 or above, you need at least one weight-related comorbidity.
If you are not sure whether a health condition you have qualifies, ask your GP to review your eligibility. Many people are surprised to find they meet the criteria when the full list of qualifying conditions is considered.
Even if you meet the BMI and comorbidity criteria, Wegovy cannot be prescribed on the NHS if specific contraindications apply.
Your GP and the specialist team will review your full medical history before any prescription is considered.
If you do not meet the NHS eligibility criteria, or you meet them but face an unacceptable wait, private prescription is the main alternative.
Private providers apply different eligibility criteria, typically lower. Most private clinics will consider prescribing Wegovy if you have a BMI of 30 or above, or a BMI of 27 or above with a weight-related health condition.
Private Wegovy costs approximately £130 to £295 per month depending on dose, with the maintenance dose, 2.4mg, at the higher end.
The advantages of private prescription are speed of access, typically 3 days to 2 weeks from initial consultation, no referral required, no two-year limit, and access for patients who do not meet NHS criteria.
The disadvantage is cost. Over a 12-month course, private treatment can represent approximately £2,400 to £3,600 in medication costs alone, plus consultation and monitoring fees.
| Route | Typical cost | Eligibility | Access speed | Treatment limit |
|---|---|---|---|---|
| NHS | Free or £9.90/item in England | BMI 35+ usually required | Often 12 to 24 months | Maximum 2 years |
| Private | £130 to £295/month | BMI 30+ typically accepted | Usually within days | No fixed two-year limit |
| Scotland, Wales and Northern Ireland | NHS prescriptions are free | Specialist eligibility still applies | Varies by local service | NHS criteria apply |
The NHS is actively working to expand access, but progress is slow relative to demand. There are an estimated 3.4 million people in England who meet the NICE eligibility criteria for weight loss medication.
The expansion of digital Tier 3 services such as Oviva, which can process patients in around ten weeks compared to the standard multi-year wait, is one of the most promising developments.
For Wegovy specifically, the NICE two-year cap and specialist-only prescribing requirement mean access is unlikely to expand to GPs in the near term. Mounjaro, by contrast, is being rolled out through GP surgeries under the phased NHS rollout that began in June 2025.
No. GPs cannot directly prescribe Wegovy for weight loss on the NHS. They can only refer you to a specialist weight management service, which will assess your eligibility and prescribe if appropriate.
If you qualify and are prescribed Wegovy through an NHS specialist service, you pay only the standard NHS prescription charge, currently £9.90 per item in England. In Scotland, Wales and Northern Ireland, NHS prescriptions are free.
Both contain semaglutide, but at different doses and with different licences. Wegovy is licensed specifically for weight management at 2.4mg. Ozempic is licensed for type 2 diabetes at lower doses and is not available on the NHS for weight loss.
Waiting times vary widely by location, from several months in areas with digital services or well-resourced Tier 3 teams, to two years or more in many parts of England.
Yes, in principle. Being on private Wegovy does not prevent you from joining an NHS waiting list or receiving an NHS prescription if you become eligible. You would still need to meet all standard eligibility criteria at the point of NHS prescribing.
If your GP declines to refer you and you believe you meet the criteria, you can ask for a second opinion or request your reasons for refusal in writing. You can also self-refer to some NHS Tier 3 services.
If you decide that waiting for the NHS is not right for you, CompareTheShot compares regulated UK clinics offering Wegovy by price, speed, support and reviews — helping you find the best option at the lowest cost.
This article is for informational purposes only and does not constitute medical advice. Eligibility criteria and waiting times are correct at the time of writing but are subject to change.
Always consult a qualified healthcare professional before starting any medication. CompareTheShot is an independent comparison service — some links on our site may be affiliate links.
Medically reviewed: May 2025. Next review due: November 2025.